Login to Your Account



ParAllele, Roche Seek Mutations Associated With Type II Diabetes

By Brady Huggett


Wednesday, September 17, 2003
ParAllele BioScience Inc., as part of its move to the commercial side of things, signed a deal with Hoffmann-La Roche Inc. to discover genes and genetic variations around Type II diabetes. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription